These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 8455720
1. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Beinborn M, Lee YM, McBride EW, Quinn SM, Kopin AS. Nature; 1993 Mar 25; 362(6418):348-50. PubMed ID: 8455720 [Abstract] [Full Text] [Related]
3. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. Mantamadiotis T, Baldwin GS. Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1382-9. PubMed ID: 8024583 [Abstract] [Full Text] [Related]
4. Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin. Wu SV, Yang M, Avedian D, Birnbaumer M, Walsh JH. Mol Pharmacol; 1999 May 30; 55(5):795-803. PubMed ID: 10220557 [Abstract] [Full Text] [Related]
8. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog. Jensen TN, Nielsen J, Frederiksen K, Ebert B. Eur J Pharmacol; 2006 May 24; 538(1-3):23-31. PubMed ID: 16647053 [Abstract] [Full Text] [Related]
9. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis. Jagerschmidt A, Guillaume N, Roques BP, Noble F. Mol Pharmacol; 1998 May 24; 53(5):878-85. PubMed ID: 9584214 [Abstract] [Full Text] [Related]
11. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist. Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ. Mol Pharmacol; 2004 Sep 24; 66(3):545-52. PubMed ID: 15322246 [Abstract] [Full Text] [Related]
12. Two amino acids in the sixth transmembrane segment of the mouse gastrin-releasing peptide receptor are important for receptor activation. Lin Y, Jian X, Lin Z, Kroog GS, Mantey S, Jensen RT, Battey J, Northup J. J Pharmacol Exp Ther; 2000 Sep 24; 294(3):1053-62. PubMed ID: 10945859 [Abstract] [Full Text] [Related]
13. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin. Foucaud M, Archer-Lahlou E, Marco E, Tikhonova IG, Maigret B, Escrieut C, Langer I, Fourmy D. Regul Pept; 2008 Jan 10; 145(1-3):17-23. PubMed ID: 17961734 [Abstract] [Full Text] [Related]
14. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding. Zhao MM, Hwa J, Perez DM. Mol Pharmacol; 1996 Nov 10; 50(5):1118-26. PubMed ID: 8913343 [Abstract] [Full Text] [Related]
15. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD. Protein Sci; 1999 Nov 10; 8(11):2347-54. PubMed ID: 10595537 [Abstract] [Full Text] [Related]
16. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Béhé M, Behr TM. Biopolymers; 2002 Nov 10; 66(6):399-418. PubMed ID: 12658727 [Abstract] [Full Text] [Related]